Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancer
2007

Impact of Clinicopathologic Factors in Breast Cancer Treatment

Sample size: 145 publication Evidence: moderate

Author Information

Author(s): Keam Bhumsuk, Im Seock-Ah, Kim Hee-Jun, Oh Do-Youn, Kim Jee Hyun, Lee Se-Hoon, Chie Eui Kyu, Han Wonshik, Kim Dong-Wan, Moon Woo Kyung, Kim Tae-You, Park In Ae, Noh Dong-Young, Heo Dae Seog, Ha Sung Whan, Bang Yung-Jue

Primary Institution: Seoul National University College of Medicine

Hypothesis

What are the predictive and prognostic factors in breast cancer patients treated with neoadjuvant chemotherapy?

Conclusion

Triple negative breast cancer patients showed a higher response rate to chemotherapy but had shorter survival compared to non-triple negative patients.

Supporting Evidence

  • Patients with triple negative phenotype showed higher response rates to chemotherapy.
  • Relapse free survival and overall survival were significantly shorter in triple negative breast cancer patients.
  • Initial clinical stage was the only significant independent prognostic factor impacting overall survival.

Takeaway

This study looked at breast cancer patients who received special chemotherapy and found that those with a certain type of cancer (triple negative) responded well to treatment but didn't live as long.

Methodology

145 stage II and III breast cancer patients received neoadjuvant docetaxel/doxorubicin chemotherapy, and clinical outcomes were analyzed in relation to various clinicopathologic parameters.

Limitations

The study had a relatively short follow-up period of 18.6 months, which may limit the understanding of long-term outcomes.

Participant Demographics

Median age of participants was 45 years, with a range from 25 to 69 years; most were clinical stage III at diagnosis.

Statistical Information

P-Value

p = 0.012

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1471-2407-7-203

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication